ReviewDrug safety2019

Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology.

Rashmi R Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.